A staff scientist of Living Cell Technologies (LCT) works at a laboratory in the LCT headquarters in Auckland

 
A staff scientist of Living Cell Technologies (LCT) works at a laboratory in the LCT headquarters in Auckland
A staff scientist of Living Cell Technologies (LCT) works at a laboratory in the LCT headquarters in Auckland in this undated picture obtained by Reuters on April 17, 2012. A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson's disease and help improve movement and brain functions in patients. To match story PARKINSONS-PIG-CELLS/ REUTERS/Living Cell Technologies/Handout (NEW ZEALAND - Tags: HEALTH SCIENCE TECHNOLOGY) FOR EDITORIAL USE ONLY. NOT FOR SALE FOR MARKETING OR ADVERTISING CAMPAIGNS. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. IT IS DISTRIBUTED, EXACTLY AS RECEIVED BY REUTERS, AS A SERVICE TO CLIENTS